Skip to content

Effect of tranexamic acid on blood loss after coronary artery bypass grafting in patients treated with clopidogrel

Effect of tranexamic acid on blood loss after coronary artery bypass grafting in patients treated with clopidogrel

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201309125381N8
Enrollment
80
Registered
2013-09-21
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding after CABG. Haemorrhage and haematoma complicating a procedure, not elsewhere classified

Interventions

Intervention 1: 15 mg/kg tranexamic acid was infused intravenously before surgical incision, and 15 mg/kg after protamine neutralization. Intervention 2: normal saline was infused intravenously before
Treatment - Drugs
15 mg/kg tranexamic acid was infused intravenously before surgical incision, and 15 mg/kg after protamine neutralization.
normal saline was infused intravenously before surgical incision, and after protamine neutralization.

Sponsors

Vice-chancellor of Research Babol University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
36 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients undergoing on-pump CABG who received clopidogrel with their last ingestion less than5 days preoperatively. Exclusion criteria: previous cardiac surgery; hematocrit less than 33%; platelet count less than 100,000/mL; or allergy to tranexamic acid; renal failure(cr>2), hepatic failure; history of bleeding diasthesis; abnormal coagulation test; previous cardiac surgerry.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Bleeding after CABG. Timepoint: 24 houres. Method of measurement: Measuring mediastinal drainage into the chest bottle.

Secondary

MeasureTime frame
Blood and blood products transfusion after CABG. Timepoint: 24 hours. Method of measurement: Measuring units of blood and blood products tranfused during and after CABG.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nadia Banihashem

Babol University of Medical Sciences

nbanihashem@yahoo.com+98 11 1223 8296

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026